Molecular Vision Ltd. of London and Acrongenomics Inc. of Geneva have presented an update on their $6.5 million joint collaboration to develop the BioLED system. The former company has focused on development of point-of-care diagnostic devices that incorporate both microfluidic components and organic polymer LEDs. Acrongenomics has helped commercialize the technology.